Option Care Health terminates merger with Amedisys, receives $106M termination fee

Option Care Health, Inc.

Option Care Health received $106M cash termination fee from Amedisys upon mutual termination of merger agreement.
Merger Agreement, announced May 3, 2023, terminated June 26, 2023; mutual release of all claims.
CEO John Rademacher cites disciplined acquisition approach and confidence in growth trajectory.
Option Care Health will incorporate termination fee into capital allocation strategy.

item 1.02 item 1.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Option Care Health, Inc. terminated Merger Agreement with Amedisys, Inc. valued at $106 million (effective 2023-06-26).

Action: termination
Agreement: merger
Counterparty: Amedisys, Inc.
Value: $106 million
Effective: 2023-06-26

Exact text from the filing

nd wholly-owned subsidiary of the Company (“Merger Sub”), and Amedisys, Inc., a Delaware corporation (“Amedisys”), entered into an Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which, and on the terms and subject to

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Option Care Health, Inc. entered into Mutual Termination Agreement with Amedisys, Inc. valued at $106 million (effective 2023-06-26).

Action: entry
Agreement: merger
Counterparty: Amedisys, Inc.
Value: $106 million
Effective: 2023-06-26

Exact text from the filing

On June 26, 2023, the Company, Merger Sub and Amedisys entered into an agreement to terminate the Merger Agreement (the “Mutual Termination Agreement”).

View on SEC.gov

281 material agreements filed in the last 30 days. Browse all material agreements →

Option Care Health, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-074575

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.